|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 152.4 EUR | -0.85% |
|
+3.50% | +5.73% |
| Apr. 23 | US competitor Danaher boosts Merck KGaA and Sartorius | DP |
| Apr. 19 | MERCK KGAA : Barclays reiterates its Buy rating | ZD |
FRANKFURT (Reuters) - Germany's Merck KGaA, which is taking over U.S. electronic chemicals maker Versum Materials, said it expected a slight tailwind from foreign exchange effects supporting earnings growth this year.
Merck on Tuesday confirmed its guidance for an underlying increase of 10-13% in 2019 earnings before interest, taxes, depreciation and amortisation (EBITDA) and adjusted for one-off items but now sees a positive effect of 0% to +2% from currencies.
It had previously seen a 3-4% drag from foreign exchange effects.
First-quarter EBITDA, adjusted for special items, slipped 4% to 929 million euros (806 million pounds), below the average analyst estimate of 944 million in a Reuters poll.
Price
|
Change
|
5d. change
|
Capi.
| ||
|---|---|---|---|---|---|
| 127 USD | +0.09% | +1.30% | 321B | ||
| - USD | -.--% | +1.03% | 5.79B | ||
| 1st Jan change | Capi. | |
|---|---|---|
| +5.73% | 71.48B | |
| +11.69% | 9.18B | |
| -15.34% | 4.79B | |
| +34.54% | 3.98B | |
| +5.09% | 3.97B | |
| +27.76% | 2.56B | |
| -28.33% | 2.29B | |
| -24.15% | 2.23B | |
| +6.23% | 1.92B | |
| -0.50% | 1.64B |
MERCK KGAA 
